{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:28:10Z","timestamp":1793899690199,"version":"4.8.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007480","name":"Universidad de Castilla-La Mancha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00415-026-14143-y","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:56:12Z","timestamp":1789649772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of neuropsychiatric and seizure disorders in neurofibromatosis type 1: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5631-8337","authenticated-orcid":false,"given":"Elena","family":"Moreno-Charco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-8752","authenticated-orcid":false,"given":"Carlos","family":"Pascual-Morena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-1618","authenticated-orcid":false,"given":"Celia","family":"\u00c1lvarez-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8496-628X","authenticated-orcid":false,"given":"Blanca","family":"Zuheros-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7835-6953","authenticated-orcid":false,"given":"Irene","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Mart\u00ednez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3042-5643","authenticated-orcid":false,"given":"Miguel","family":"Contreras-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3470-1724","authenticated-orcid":false,"given":"Silvana","family":"Pati\u00f1o-Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"14143_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH et al (2017) Neurofibromatosis type 1. Nat Rev Dis Primers 3:17004. https:\/\/doi.org\/10.1038\/nrdp.2017.4","journal-title":"Nat Rev Dis Primers"},{"key":"14143_CR2","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P et al (2021) Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med 23:1506\u20131513. https:\/\/doi.org\/10.1038\/s41436-021-01170-5","journal-title":"Genet Med"},{"key":"14143_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrc3911","volume":"15","author":"N Ratner","year":"2015","unstructured":"Ratner N, Miller SJ (2015) A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer 15:290\u2013301. https:\/\/doi.org\/10.1038\/nrc3911","journal-title":"Nat Rev Cancer"},{"key":"14143_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17233788","volume":"17","author":"Y Lu","year":"2025","unstructured":"Lu Y, Xu M, Chen X et al (2025) Neurofibromatosis type 1: genetic mechanisms and advances in therapeutic innovation. Cancers (Basel) 17:3788. https:\/\/doi.org\/10.3390\/cancers17233788","journal-title":"Cancers (Basel)"},{"key":"14143_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/B978-0-444-52902-2.00053-9","volume":"115","author":"RE Ferner","year":"2013","unstructured":"Ferner RE, Gutmann DH (2013) Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol 115:939\u2013955. https:\/\/doi.org\/10.1016\/B978-0-444-52902-2.00053-9","journal-title":"Handb Clin Neurol"},{"key":"14143_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02911-2","volume":"18","author":"T-SJ Lee","year":"2023","unstructured":"Lee T-SJ, Chopra M, Kim RH et al (2023) Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis. Orphanet J Rare Dis 18:292. https:\/\/doi.org\/10.1186\/s13023-023-02911-2","journal-title":"Orphanet J Rare Dis"},{"key":"14143_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","volume":"13","author":"AC Hirbe","year":"2014","unstructured":"Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13:834\u2013843. https:\/\/doi.org\/10.1016\/S1474-4422(14)70063-8","journal-title":"Lancet Neurol"},{"key":"14143_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N et al (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81\u201388. https:\/\/doi.org\/10.1136\/jmg.2006.045906","journal-title":"J Med Genet"},{"key":"14143_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.tins.2012.12.002","volume":"36","author":"KA Diggs-Andrews","year":"2013","unstructured":"Diggs-Andrews KA, Gutmann DH (2013) Modeling cognitive dysfunction in neurofibromatosis-1. Trends Neurosci 36:237\u2013247. https:\/\/doi.org\/10.1016\/j.tins.2012.12.002","journal-title":"Trends Neurosci"},{"key":"14143_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.14348\/molcells.2019.0037","volume":"42","author":"YE Kim","year":"2019","unstructured":"Kim YE, Baek ST (2019) Neurodevelopmental aspects of RASopathies. Mol Cells 42:441\u2013447. https:\/\/doi.org\/10.14348\/molcells.2019.0037","journal-title":"Mol Cells"},{"key":"14143_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/children11081033","volume":"11","author":"ND Cavallo","year":"2024","unstructured":"Cavallo ND, Maietta P, Perrotta S et al (2024) Quality of life in children with neurofibromatosis type 1: agreement between parents and patients, and the role of disease severity and visibility. Children (Basel) 11:1033. https:\/\/doi.org\/10.3390\/children11081033","journal-title":"Children (Basel)"},{"key":"14143_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1640309","volume":"16","author":"Y Ren","year":"2025","unstructured":"Ren Y, Hu W, Su S et al (2025) Recent advances of epilepsy associated with neurofibromatosis type 1. Front Neurol 16:1640309. https:\/\/doi.org\/10.3389\/fneur.2025.1640309","journal-title":"Front Neurol"},{"key":"14143_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/gim.2018.28","volume":"20","author":"DR Stewart","year":"2018","unstructured":"Stewart DR, Korf BR, Nathanson KL et al (2018) Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 20:671\u2013682. https:\/\/doi.org\/10.1038\/gim.2018.28","journal-title":"Genet Med"},{"key":"14143_CR14","doi-asserted-by":"crossref","unstructured":"Shilyansky C, Lee YS, Silva AJ (2010) Molecular and Cellular Mechanisms of Learning Disabilities: A Focus on NF1. In: Hyman SE (ed) Annual review of neuroscience 33:221\u2013243. https:\/\/doi.org\/10.1146\/annurev-neuro-060909-153215","DOI":"10.1146\/annurev-neuro-060909-153215"},{"key":"14143_CR15","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. J Am Med Assoc 283:2008\u20132012. https:\/\/doi.org\/10.1001\/jama.283.15.2008","journal-title":"J Am Med Assoc"},{"key":"14143_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"14143_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J et al (2019) Cochrane handbook for systematic reviews of interventions. Cochrane Handbook Systematic Rev Interv. https:\/\/doi.org\/10.1002\/9781119536604","journal-title":"Cochrane Handbook Systematic Rev Interv"},{"key":"14143_CR18","unstructured":"Boat TF, Wu JT, Disorders C to E the SSIDP for C with M, et al (2015) Mental Disorders and Disabilities Among Low-Income Children. Washington (DC): National Academies Press (US)"},{"key":"14143_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/j.2051-5545.2011.tb00045.x","volume":"10","author":"L Salvador-Carulla","year":"2011","unstructured":"Salvador-Carulla L, Reed GM, Vaez-Azizi LM et al (2011) Intellectual developmental disorders: towards a new name, definition and framework for \u201cmental retardation\/intellectual disability\u201d in ICD-11. World Psychiatry 10:175\u2013180. https:\/\/doi.org\/10.1002\/j.2051-5545.2011.tb00045.x","journal-title":"World Psychiatry"},{"key":"14143_CR20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S2352-4642(22)00067-0","volume":"6","author":"V Totsika","year":"2022","unstructured":"Totsika V, Liew A, Absoud M et al (2022) Mental health problems in children with intellectual disability. Lancet Child Adolesc Health 6:432\u2013444. https:\/\/doi.org\/10.1016\/S2352-4642(22)00067-0","journal-title":"Lancet Child Adolesc Health"},{"key":"14143_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000054","author":"Z Munn","year":"2015","unstructured":"Munn Z, MClinSc SM, Lisy K, et al (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. https:\/\/doi.org\/10.1097\/XEB.0000000000000054","journal-title":"Int J Evid Based Healthc"},{"key":"14143_CR22","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/sim.1262","volume":"21","author":"K Sidik","year":"2002","unstructured":"Sidik K, Jonkman JN (2002) A simple confidence interval for meta-analysis. Stat Med 21:3153\u20133159. https:\/\/doi.org\/10.1002\/sim.1262","journal-title":"Stat Med"},{"key":"14143_CR23","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"key":"14143_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"14143_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/eb-2013-101699","volume":"17","author":"D Mavridis","year":"2014","unstructured":"Mavridis D, Salanti G (2014) How to assess publication bias: funnel plot, trim-and-fill method and selection models. Evid Based Ment Health 17:30. https:\/\/doi.org\/10.1136\/eb-2013-101699","journal-title":"Evid Based Ment Health"},{"key":"14143_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/heartjnl-2016-309685","volume":"103","author":"A Kiran","year":"2017","unstructured":"Kiran A, Crespillo AP, Rahimi K (2017) Graphics and statistics for cardiology: data visualisation for meta-analysis. Heart 103:19\u201323. https:\/\/doi.org\/10.1136\/heartjnl-2016-309685","journal-title":"Heart"},{"key":"14143_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1214\/aoms\/1177729756","volume":"21","author":"MF Freeman","year":"1950","unstructured":"Freeman MF, Tukey JW (1950) Transformations related to the angular and the square root. Ann Math Stat 21:607\u2013611","journal-title":"Ann Math Stat"},{"key":"14143_CR28","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/08830738251396193","volume":"41","author":"T Acehan","year":"2025","unstructured":"Acehan T, Harputlu Yamak Y, G\u00fcrb\u00fcz \u015e et al (2025) Family functioning, anxiety, and depressive symptoms and their impact on quality of life in children with neurofibromatosis type 1. J Child Neurol 41:971\u2013981. https:\/\/doi.org\/10.1177\/08830738251396193","journal-title":"J Child Neurol"},{"key":"14143_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/jmedgenet-2013-101951","volume":"51","author":"B Adviento","year":"2014","unstructured":"Adviento B, Corbin IL, Widjaja F et al (2014) Autism traits in the RASopathies. J Med Genet 51:10\u201320. https:\/\/doi.org\/10.1136\/jmedgenet-2013-101951","journal-title":"J Med Genet"},{"key":"14143_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1037\/fam0001256","volume":"39","author":"N Al Ghriwati","year":"2025","unstructured":"Al Ghriwati N, Little P, Martin S et al (2025) Parent-child discrepancies in reports of child psychosocial functioning in neurofibromatosis type 1. J Fam Psychol 39:99\u2013106. https:\/\/doi.org\/10.1037\/fam0001256","journal-title":"J Fam Psychol"},{"key":"14143_CR31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37385","volume":"15","author":"MA Alfurayh","year":"2023","unstructured":"Alfurayh MA, Alawad NK, Bin Akrish AM et al (2023) Phenotype and genotype of Saudi pediatric patients with neurofibromatosis type 1: a seven-year multicenter experience from Saudi Arabia. Cureus 15:e37385. https:\/\/doi.org\/10.7759\/cureus.37385","journal-title":"Cureus"},{"key":"14143_CR32","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2147\/JMDH.S454921","volume":"17","author":"M Almuqbil","year":"2024","unstructured":"Almuqbil M, Alshaikh FY, Altwaijri W et al (2024) Epidemiology and outcomes of neurofibromatosis type 1 (NF-1): multicenter tertiary experience. J Multidiscip Healthc 17:1303\u20131314. https:\/\/doi.org\/10.2147\/JMDH.S454921","journal-title":"J Multidiscip Healthc"},{"key":"14143_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.17712\/nsj.2020.5.20200081","volume":"25","author":"FA Bashiri","year":"2020","unstructured":"Bashiri FA, Alzamil LR, Aldhuwayhi RA (2020) Clinical spectrum of neurofibromatosis type 1 among children in a tertiary care center. Neurosci 25:375\u2013379. https:\/\/doi.org\/10.17712\/nsj.2020.5.20200081","journal-title":"Neurosci"},{"key":"14143_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1017\/s0317167100004017","volume":"32","author":"JM Boulanger","year":"2005","unstructured":"Boulanger JM, Larbrisseau A (2005) Neurofibromatosis type 1 in a pediatric population: Ste-Justine\u2019s experience. Can J Neurol Sci 32:225\u2013231. https:\/\/doi.org\/10.1017\/s0317167100004017","journal-title":"Can J Neurol Sci"},{"key":"14143_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/cge.12551","volume":"88","author":"JS Cohen","year":"2015","unstructured":"Cohen JS, Levy HP, Sloan J et al (2015) Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life. Clin Genet 88:425\u2013430. https:\/\/doi.org\/10.1111\/cge.12551","journal-title":"Clin Genet"},{"key":"14143_CR36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ridd.2015.11.010","volume":"48","author":"V Coutinho","year":"2016","unstructured":"Coutinho V, Kemlin I, Dorison N et al (2016) Neuropsychological evaluation and parental assessment of behavioral and motor difficulties in children with neurofibromatosis type 1. Res Dev Disabil 48:220\u2013230. https:\/\/doi.org\/10.1016\/j.ridd.2015.11.010","journal-title":"Res Dev Disabil"},{"key":"14143_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/brain\/122.3.473","volume":"122","author":"A Cr\u00e9ange","year":"1999","unstructured":"Cr\u00e9ange A, Zeller J, Rostaing-Rigattieri S et al (1999) Neurological complications of neurofibromatosis type 1 in adulthood. Brain 122:473\u2013481. https:\/\/doi.org\/10.1093\/brain\/122.3.473","journal-title":"Brain"},{"key":"14143_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03454-w","volume":"19","author":"K Doser","year":"2024","unstructured":"Doser K, Jepsen JRM, Kenborg L et al (2024) Neurocognitive functioning in adults with neurofibromatosis type 1- a nationwide population-based study. Orphanet J Rare Dis 19:441. https:\/\/doi.org\/10.1186\/s13023-024-03454-w","journal-title":"Orphanet J Rare Dis"},{"key":"14143_CR39","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s10803-018-3478-0","volume":"48","author":"S Eijk","year":"2018","unstructured":"Eijk S, Mous SE, Dieleman GC et al (2018) Autism spectrum disorder in an unselected cohort of children with neurofibromatosis type 1 (NF1). J Autism Dev Disord 48:2278\u20132285. https:\/\/doi.org\/10.1007\/s10803-018-3478-0","journal-title":"J Autism Dev Disord"},{"key":"14143_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-510x(96)00022-6","volume":"138","author":"RE Ferner","year":"1996","unstructured":"Ferner RE, Hughes RA, Weinman J (1996) Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138:125\u2013133. https:\/\/doi.org\/10.1016\/0022-510x(96)00022-6","journal-title":"J Neurol Sci"},{"key":"14143_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-021-09414-w","volume":"14","author":"AMH Foy","year":"2022","unstructured":"Foy AMH, Hudock RL, Shanley R, Pierpont EI (2022) Social behavior in RASopathies and idiopathic autism. J Neurodev Disord 14:5. https:\/\/doi.org\/10.1186\/s11689-021-09414-w","journal-title":"J Neurodev Disord"},{"key":"14143_CR42","doi-asserted-by":"publisher","first-page":"e1642","DOI":"10.1542\/peds.2013-1868","volume":"132","author":"S Garg","year":"2013","unstructured":"Garg S, Green J, Leadbitter K et al (2013) Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics 132:e1642\u2013e1648. https:\/\/doi.org\/10.1542\/peds.2013-1868","journal-title":"Pediatrics"},{"key":"14143_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2024.107336","volume":"202","author":"J H\u00e9bert","year":"2024","unstructured":"H\u00e9bert J, De Santis RJ, Daniyal L et al (2024) Epilepsy in neurofibromatosis type 1: prevalence, phenotype, and genotype in adults. Epilepsy Res 202:107336. https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107336","journal-title":"Epilepsy Res"},{"key":"14143_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9493837","author":"M Heimg\u00e4rtner","year":"2019","unstructured":"Heimg\u00e4rtner M, Granstr\u00f6m S, Haas-Lude K et al (2019) Attention deficit predicts intellectual functioning in children with neurofibromatosis type 1. Int J Pediatr. https:\/\/doi.org\/10.1155\/2019\/9493837","journal-title":"Int J Pediatr"},{"key":"14143_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/21622965.2024.2365383","volume":"15","author":"MC Hocking","year":"2026","unstructured":"Hocking MC, Albee MV, Kim M et al (2026) Social challenges, autism spectrum disorder, and attention deficit\/hyperactivity disorder in youth with neurofibromatosis type I. Appl Neuropsychol Child 15:33\u201341. https:\/\/doi.org\/10.1080\/21622965.2024.2365383","journal-title":"Appl Neuropsychol Child"},{"key":"14143_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1017\/s0012162205000460","volume":"47","author":"H Johnson","year":"2005","unstructured":"Johnson H, Wiggs L, Stores G, Huson SM (2005) Psychological disturbance and sleep disorders in children with neurofibromatosis type 1. Dev Med Child Neurol 47:237\u2013242. https:\/\/doi.org\/10.1017\/s0012162205000460","journal-title":"Dev Med Child Neurol"},{"key":"14143_CR47","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1002\/ajmg.a.62436","volume":"185","author":"L Kenborg","year":"2021","unstructured":"Kenborg L, Andersen EW, Duun-Henriksen AK et al (2021) Psychiatric disorders in individuals with neurofibromatosis 1 in Denmark: a nationwide register-based cohort study. Am J Med Genet A 185:3706\u20133716. https:\/\/doi.org\/10.1002\/ajmg.a.62436","journal-title":"Am J Med Genet A"},{"key":"14143_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/2329048X221131445","author":"AM Khair","year":"2022","unstructured":"Khair AM, Falchek S, Nikam R, Kaur G (2022) Epilepsy and electroencephalogram characteristics in children with neurofibromatosis type 1 what we have learned from a tertiary center five years\u2019 experience. Child Neurol Open. https:\/\/doi.org\/10.1177\/2329048X221131445","journal-title":"Child Neurol Open"},{"key":"14143_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1017\/S1355617713001227","volume":"20","author":"BP Klein-Tasman","year":"2014","unstructured":"Klein-Tasman BP, Janke KM, Luo W et al (2014) Cognitive and psychosocial phenotype of young children with neurofibromatosis-1. J Int Neuropsychol Soc 20:88\u201398. https:\/\/doi.org\/10.1017\/S1355617713001227","journal-title":"J Int Neuropsychol Soc"},{"key":"14143_CR50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1076\/chin.6.3.185.3155","volume":"6","author":"CW Koth","year":"2000","unstructured":"Koth CW, Cutting LE, Denckla MB (2000) The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder. Child Neuropsychol 6:185\u2013194. https:\/\/doi.org\/10.1076\/chin.6.3.185.3155","journal-title":"Child Neuropsychol"},{"key":"14143_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15212690","volume":"15","author":"R Kravljanac","year":"2025","unstructured":"Kravljanac R, Be\u0111ik J, Bruno I et al (2025) Clinical characteristics of seizures and course of epilepsy in children with neurofibromatosis type 1-a tertiary center experience in a cohort of 118 children. Diagnostics (Basel) 15:2690. https:\/\/doi.org\/10.3390\/diagnostics15212690","journal-title":"Diagnostics (Basel)"},{"key":"14143_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02356-z","volume":"17","author":"S Lausdahl","year":"2022","unstructured":"Lausdahl S, Handrup MM, Rubak SL et al (2022) Transition to adult care of young patients with neurofibromatosis type 1 and cognitive deficits: a single-centre study. Orphanet J Rare Dis 17:208. https:\/\/doi.org\/10.1186\/s13023-022-02356-z","journal-title":"Orphanet J Rare Dis"},{"key":"14143_CR53","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/dmcn.12734","volume":"57","author":"A Lehtonen","year":"2015","unstructured":"Lehtonen A, Garg S, Roberts SA et al (2015) Cognition in children with neurofibromatosis type 1: data from a population-based study. Dev Med Child Neurol 57:645\u2013651. https:\/\/doi.org\/10.1111\/dmcn.12734","journal-title":"Dev Med Child Neurol"},{"key":"14143_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.852208","volume":"13","author":"K Lubbers","year":"2022","unstructured":"Lubbers K, Stijl EM, Dierckx B et al (2022) Autism symptoms in children and young adults with fragile X syndrome, Angelman syndrome, tuberous sclerosis complex, and neurofibromatosis type 1: a cross-syndrome comparison. Front Psychiatry 13:852208. https:\/\/doi.org\/10.3389\/fpsyt.2022.852208","journal-title":"Front Psychiatry"},{"key":"14143_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/gim.2014.70","volume":"17","author":"CC Madubata","year":"2015","unstructured":"Madubata CC, Olsen MA, Stwalley DL et al (2015) Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis. Genet Med 17:36\u201342. https:\/\/doi.org\/10.1038\/gim.2014.70","journal-title":"Genet Med"},{"key":"14143_CR56","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1002\/ajmg.a.61361","volume":"179","author":"AM McNeill","year":"2019","unstructured":"McNeill AM, Hudock RL, Foy AMH et al (2019) Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome. Am J Med Genet A 179:2433\u20132446. https:\/\/doi.org\/10.1002\/ajmg.a.61361","journal-title":"Am J Med Genet A"},{"key":"14143_CR57","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/dmcn.14558","volume":"63","author":"H Morotti","year":"2021","unstructured":"Morotti H, Mastel S, Keller K et al (2021) Autism and attention-deficit\/hyperactivity disorders and symptoms in children with neurofibromatosis type 1. Dev Med Child Neurol 63:226\u2013232. https:\/\/doi.org\/10.1111\/dmcn.14558","journal-title":"Dev Med Child Neurol"},{"key":"14143_CR58","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamapsychiatry.2016.2600","volume":"73","author":"SM Morris","year":"2016","unstructured":"Morris SM, Acosta MT, Garg S et al (2016) Disease burden and symptom structure of autism in neurofibromatosis type 1: a study of the International NF1-ASD Consortium Team (INFACT). JAMA Psychiat 73:1276\u20131284. https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.2600","journal-title":"JAMA Psychiat"},{"key":"14143_CR59","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/epi.12348","volume":"54","author":"AP Ostendorf","year":"2013","unstructured":"Ostendorf AP, Gutmann DH, Weisenberg JLZ (2013) Epilepsy in individuals with neurofibromatosis type 1. Epilepsia 54:1810\u20131814. https:\/\/doi.org\/10.1111\/epi.12348","journal-title":"Epilepsia"},{"key":"14143_CR60","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ejpn.2018.04.016","volume":"22","author":"A Parmeggiani","year":"2018","unstructured":"Parmeggiani A, Boiani F, Capponi S et al (2018) Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: preliminary results. Eur J Paediatr Neurol 22:822\u2013830. https:\/\/doi.org\/10.1016\/j.ejpn.2018.04.016","journal-title":"Eur J Paediatr Neurol"},{"key":"14143_CR61","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.yebeh.2017.05.011","volume":"73","author":"A Pecoraro","year":"2017","unstructured":"Pecoraro A, Arehart E, Gallentine W et al (2017) Epilepsy in neurofibromatosis type 1. Epilepsy Behav 73:137\u2013141. https:\/\/doi.org\/10.1016\/j.yebeh.2017.05.011","journal-title":"Epilepsy Behav"},{"key":"14143_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s11689-018-9239-8","volume":"10","author":"EI Pierpont","year":"2018","unstructured":"Pierpont EI, Hudock RL, Foy AM et al (2018) Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. J Neurodev Disord 10:21. https:\/\/doi.org\/10.1186\/s11689-018-9239-8","journal-title":"J Neurodev Disord"},{"key":"14143_CR63","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ajmg.b.32280","volume":"168B","author":"E Plasschaert","year":"2015","unstructured":"Plasschaert E, Descheemaeker M-J, Van Eylen L et al (2015) Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. Am J Med Genet B Neuropsychiatr Genet 168B:72\u201380. https:\/\/doi.org\/10.1002\/ajmg.b.32280","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"14143_CR64","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1080\/87565641.2012.695831","volume":"37","author":"NA Pride","year":"2012","unstructured":"Pride NA, Payne JM, North KN (2012) The impact of ADHD on the cognitive and academic functioning of children with NF1. Dev Neuropsychol 37:590\u2013600. https:\/\/doi.org\/10.1080\/87565641.2012.695831","journal-title":"Dev Neuropsychol"},{"key":"14143_CR65","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajmg.b.32612","volume":"177","author":"AB Rietman","year":"2018","unstructured":"Rietman AB, van der Vaart T, Plasschaert E et al (2018) Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1. Am J Med Genet B Neuropsychiatr Genet 177:319\u2013328. https:\/\/doi.org\/10.1002\/ajmg.b.32612","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"14143_CR66","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejpn.2024.05.016","volume":"51","author":"L Routier","year":"2024","unstructured":"Routier L, Quern\u00e9 L, Fontaine C et al (2024) Distinct attentional and executive profiles in neurofibromatosis type 1: is there difference with primary attention deficit-hyperactivity disorder? Eur J Paediatr Neurol 51:93\u201399. https:\/\/doi.org\/10.1016\/j.ejpn.2024.05.016","journal-title":"Eur J Paediatr Neurol"},{"key":"14143_CR67","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nrl.2019.05.003","volume":"37","author":"SB S\u00e1nchez Marco","year":"2022","unstructured":"S\u00e1nchez Marco SB, L\u00f3pez Pis\u00f3n J, Calvo Escribano C et al (2022) Neurological manifestations of neurofibromatosis type 1: our experience. Neurologia 37:325\u2013333. https:\/\/doi.org\/10.1016\/j.nrl.2019.05.003","journal-title":"Neurologia"},{"key":"14143_CR68","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/genes16070843","volume":"16","author":"Y Serur","year":"2025","unstructured":"Serur Y, Russo O, McGhee CA, Green T (2025) Increased prevalence of psychiatric disorders in children with RASopathies: comparing NF1, Noonan syndrome spectrum disorder, and the general population. Genes (Basel) 16:843. https:\/\/doi.org\/10.3390\/genes16070843","journal-title":"Genes (Basel)"},{"key":"14143_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246336","volume":"13","author":"U Sorrentino","year":"2021","unstructured":"Sorrentino U, Bellonzi S, Mozzato C et al (2021) Epilepsy in NF1: epidemiologic, genetic, and clinical features. a monocentric retrospective study in a cohort of 784 patients. Cancers (Basel) 13:6336. https:\/\/doi.org\/10.3390\/cancers13246336","journal-title":"Cancers (Basel)"},{"key":"14143_CR70","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/ajmg.a.62544","volume":"188","author":"KL Struemph","year":"2022","unstructured":"Struemph KL, Watts ATM, Wolters PL et al (2022) Adolescents and young adults with neurofibromatosis type 1: a descriptive study of adaptive functioning. Am J Med Genet A 188:488\u2013497. https:\/\/doi.org\/10.1002\/ajmg.a.62544","journal-title":"Am J Med Genet A"},{"key":"14143_CR71","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1055\/s-2007-973086","volume":"219","author":"S Syrbe","year":"2007","unstructured":"Syrbe S, Eberle K, Strenge S et al (2007) Neurofibromatosis type 1 and associated clinical abnormalities in 27 children. Klin Padiatr 219:326\u2013332. https:\/\/doi.org\/10.1055\/s-2007-973086","journal-title":"Klin Padiatr"},{"key":"14143_CR72","doi-asserted-by":"publisher","DOI":"10.1177\/08830738261416621","author":"S van Abeelen","year":"2026","unstructured":"van Abeelen S, Hendriksen JGM, de Louw A et al (2026) Intelligence over time in children with neurofibromatosis type 1 based on a structured natural history-study. J Child Neurol. https:\/\/doi.org\/10.1177\/08830738261416621","journal-title":"J Child Neurol"},{"key":"14143_CR73","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.nrl.2017.02.010","volume":"34","author":"E Vaucheret Paz","year":"2019","unstructured":"Vaucheret Paz E, L\u00f3pez Ballent A, Puga C et al (2019) Cognitive profile and disorders affecting higher brain functions in paediatric patients with neurofibromatosis type 1. Neurologia (Barc) 34:353\u2013359. https:\/\/doi.org\/10.1016\/j.nrl.2017.02.010","journal-title":"Neurologia (Barc)"},{"key":"14143_CR74","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/dmcn.12038","volume":"55","author":"KS Walsh","year":"2013","unstructured":"Walsh KS, V\u00e9lez JI, Kardel PG et al (2013) Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Dev Med Child Neurol 55:131\u2013138. https:\/\/doi.org\/10.1111\/dmcn.12038","journal-title":"Dev Med Child Neurol"},{"key":"14143_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.32095","volume":"196","author":"JP Garzon","year":"2024","unstructured":"Garzon JP, Patete A, Aschbacher-Smith L et al (2024) Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome. Am J Med Genet C Semin Med Genet 196:e32095. https:\/\/doi.org\/10.1002\/ajmg.c.32095","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"14143_CR76","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/jmg.2009.075937","volume":"47","author":"V-F Mautner","year":"2010","unstructured":"Mautner V-F, Kluwe L, Friedrich RE et al (2010) Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J Med Genet 47:623\u2013630. https:\/\/doi.org\/10.1136\/jmg.2009.075937","journal-title":"J Med Genet"},{"key":"14143_CR77","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11910-996-0033-8","volume":"6","author":"RJ Packer","year":"2006","unstructured":"Packer RJ (2006) Neurocognitive deficits in children with neurofibromatosis type 1. Curr Neurol Neurosci Rep 6:119\u2013120. https:\/\/doi.org\/10.1007\/s11910-996-0033-8","journal-title":"Curr Neurol Neurosci Rep"},{"key":"14143_CR78","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ridd.2010.12.018","volume":"32","author":"PK Maulik","year":"2011","unstructured":"Maulik PK, Mascarenhas MN, Mathers CD et al (2011) Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 32:419\u2013436. https:\/\/doi.org\/10.1016\/j.ridd.2010.12.018","journal-title":"Res Dev Disabil"},{"key":"14143_CR79","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainres.2009.05.070","volume":"1284","author":"I Martin","year":"2009","unstructured":"Martin I, Andres CR, V\u00e9drine S et al (2009) Effect of the oligodendrocyte myelin glycoprotein (OMgp) on the expansion and neuronal differentiation of rat neural stem cells. Brain Res 1284:22\u201330. https:\/\/doi.org\/10.1016\/j.brainres.2009.05.070","journal-title":"Brain Res"},{"key":"14143_CR80","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/YPG.0000000000000100","volume":"25","author":"J Tastet","year":"2015","unstructured":"Tastet J, Decalonne L, Marouillat S et al (2015) Mutation screening of the ubiquitin ligase gene RNF135 in French patients with autism. Psychiatr Genet 25:263\u2013267. https:\/\/doi.org\/10.1097\/YPG.0000000000000100","journal-title":"Psychiatr Genet"},{"key":"14143_CR81","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ajhg.2012.10.011","volume":"91","author":"L Basel-Vanagaite","year":"2012","unstructured":"Basel-Vanagaite L, Dallapiccola B, Ramirez-Solis R et al (2012) Deficiency for the ubiquitin ligase ube3b in a blepharophimosis-ptosis- intellectual-disability syndrome. Am J Hum Genet 91:998\u20131010. https:\/\/doi.org\/10.1016\/j.ajhg.2012.10.011","journal-title":"Am J Hum Genet"},{"key":"14143_CR82","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.cell.2012.11.040","volume":"151","author":"NP Tsai","year":"2012","unstructured":"Tsai NP, Wilkerson JR, Guo W et al (2012) Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell 151:1581\u20131594. https:\/\/doi.org\/10.1016\/j.cell.2012.11.040","journal-title":"Cell"},{"key":"14143_CR83","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1017\/S003329171400172X","volume":"45","author":"AJ Baxter","year":"2015","unstructured":"Baxter AJ, Brugha TS, Erskine HE et al (2015) The epidemiology and global burden of autism spectrum disorders. Psychol Med 45:601\u2013613. https:\/\/doi.org\/10.1017\/S003329171400172X","journal-title":"Psychol Med"},{"key":"14143_CR84","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/JCPP.12381","volume":"56","author":"GV Polanczyk","year":"2015","unstructured":"Polanczyk GV, Salum GA, Sugaya LS et al (2015) Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry 56:345\u2013365. https:\/\/doi.org\/10.1111\/JCPP.12381","journal-title":"J Child Psychol Psychiatry"},{"key":"14143_CR85","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1037\/BUL0000102","volume":"143","author":"RH Salk","year":"2017","unstructured":"Salk RH, Hyde JS, Abramson LY (2017) Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms. Psychol Bull 143:783\u2013822. https:\/\/doi.org\/10.1037\/BUL0000102","journal-title":"Psychol Bull"},{"key":"14143_CR86","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S2215-0366(16)30263-2","volume":"4","author":"C Kuehner","year":"2017","unstructured":"Kuehner C (2017) Why is depression more common among women than among men? Lancet Psychiatry 4:146\u2013158. https:\/\/doi.org\/10.1016\/S2215-0366(16)30263-2","journal-title":"Lancet Psychiatry"},{"key":"14143_CR87","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","volume":"88","author":"KM Fiest","year":"2017","unstructured":"Fiest KM, Sauro KM, Wiebe S et al (2017) Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology 88:296\u2013303. https:\/\/doi.org\/10.1212\/WNL.0000000000003509","journal-title":"Neurology"},{"key":"14143_CR88","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s00381-020-04710-7","volume":"36","author":"P Bernardo","year":"2020","unstructured":"Bernardo P, Cinalli G, Santoro C (2020) Epilepsy in NF1: a systematic review of the literature. Childs Nerv Syst 36:2333\u20132350. https:\/\/doi.org\/10.1007\/s00381-020-04710-7","journal-title":"Childs Nerv Syst"},{"key":"14143_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2024.107476","volume":"208","author":"F Wu","year":"2024","unstructured":"Wu F, Ji X, Shen M et al (2024) Prevalence, clinical characteristics and outcomes of seizures in neurofibromatosis type 1: a systematic review and single arm meta-analysis. Epilepsy Res 208:107476. https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107476","journal-title":"Epilepsy Res"},{"key":"14143_CR90","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/S12916-019-1297-6","volume":"17","author":"B Levis","year":"2019","unstructured":"Levis B, Yan XW, He C et al (2019) Comparison of depression prevalence estimates in meta-analyses based on screening tools and rating scales versus diagnostic interviews: a meta-research review. BMC Med 17:65. https:\/\/doi.org\/10.1186\/S12916-019-1297-6","journal-title":"BMC Med"},{"key":"14143_CR91","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-019-02002-2","volume":"139","author":"JS Nix","year":"2020","unstructured":"Nix JS, Blakeley J, Rodriguez FJ (2020) An update on the central nervous system manifestations of neurofibromatosis type 1. Acta Neuropathol 139:625\u2013641. https:\/\/doi.org\/10.1007\/s00401-019-02002-2","journal-title":"Acta Neuropathol"},{"key":"14143_CR92","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1002\/glia.24432","volume":"71","author":"P de Blank","year":"2023","unstructured":"de Blank P, Nishiyama A, L\u00f3pez-Ju\u00e1rez A (2023) A new era for myelin research in Neurofibromatosis type 1. Glia 71:2701\u20132719. https:\/\/doi.org\/10.1002\/glia.24432","journal-title":"Glia"},{"key":"14143_CR93","doi-asserted-by":"publisher","DOI":"10.1172\/JCI188932","volume":"135","author":"SJ Park","year":"2025","unstructured":"Park SJ, Lukkes JL, Chan K-K et al (2025) A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+\/- mice. J Clin Invest 135:e188932. https:\/\/doi.org\/10.1172\/JCI188932","journal-title":"J Clin Invest"},{"key":"14143_CR94","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1212\/WNL.0000000000012436","volume":"97","author":"C Bettegowda","year":"2021","unstructured":"Bettegowda C, Upadhayaya M, Evans DG et al (2021) Genotype-phenotype correlations in neurofibromatosis and their potential clinical use. Neurology 97:S91\u2013S98. https:\/\/doi.org\/10.1212\/WNL.0000000000012436","journal-title":"Neurology"},{"key":"14143_CR95","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/NG2083","volume":"39","author":"J Douglas","year":"2007","unstructured":"Douglas J, Cilliers D, Coleman K et al (2007) Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth. Nat Genet 39:963\u2013965. https:\/\/doi.org\/10.1038\/NG2083","journal-title":"Nat Genet"},{"key":"14143_CR96","unstructured":"Friedman JM (2025) Neurofibromatosis 1. GeneReviews [no pagination]. https:\/\/pubmed.ncbi.nlm.nih.gov\/20301288\/"},{"key":"14143_CR97","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00431-025-06648-x","volume":"184","author":"C Pascual-Morena","year":"2025","unstructured":"Pascual-Morena C, Mart\u00ednez-Garc\u00eda I, Lucer\u00f3n-Lucas-Torres M et al (2025) Prevalence of neurodevelopmental and psychiatric disorders in Noonan syndrome: a systematic review and meta-analysis. Eur J Pediatr 184:800. https:\/\/doi.org\/10.1007\/s00431-025-06648-x","journal-title":"Eur J Pediatr"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14143-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14143-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14143-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:04:17Z","timestamp":1793898257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14143-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":97,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["14143"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14143-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"5 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"603"}}